Editorial: real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease—results from the ENEIDA registry. Authors' reply

LINKED CONTENT This article is linked to Iborra et al and Frasca and Cheifetz papers. To view these articles, visit https://doi.org/10.1111/apt.15371 and https://doi.org/10.1111/apt.15405.

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2019-09, Vol.50 (5), p.600-601
Main Authors: Iborra, Marisa, Beltrán, Belén, Nos, Pilar
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized
Crohn Disease
Humans
Monoclonal antibodies
Registries
Remission Induction
Ustekinumab
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LINKED CONTENT This article is linked to Iborra et al and Frasca and Cheifetz papers. To view these articles, visit https://doi.org/10.1111/apt.15371 and https://doi.org/10.1111/apt.15405.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.15447